WGSWWGeneDx Holdings Corp. Warrant
Data unavailable—Mkt Cap: —P/E: —70d ago
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and inf…
Industry Peers
Software - Application$230.87BUSDP/E 27.6
$241.59BUSDP/E 27.5
SHOP$192.98BUSDP/E 97.7
$187.04BUSDP/E 20.8
SHOP$186.88BUSDP/E 97.3
SHOP$178.97BUSDP/E 93.2
$139.22BUSDP/E 14.9
$129.85BUSDP/E 82.0
$135.90BUSDP/E 82.2
$115.76BUSD
$103.74BUSDP/E 23.9
$96.48BUSDP/E 526.9
$91.83BUSDP/E 12.9
$89.97BUSDP/E 65.1
$71.99BUSDP/E 16.4
$62.43BUSD
$45.45BUSDP/E 38.7
$45.20BUSD
$43.30BUSDP/E 26.8
$44.12BUSDP/E 44.6
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)442.68M $
Gross Profit298.17M $
Net Income (TTM)-21.02M $
Revenue/Share15.30 USD
Last Price—
Fiscal Year End—
MR Quarter—
Employees1.3K
CountryUS
SectorTechnology
IndustrySoftware - Application
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)—
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin69.74%
Oper. Margin-25.61%
EBITDA Margin-1.77%
Profit Margin-4.92%
ROE-6.82%
ROA-4.01%
Growth
Revenue Growth17.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF33.28M $
CapEx (TTM)19.02M $
FCF Margin0.82%
FCF Yield—
Net Debt-2.49M $
Net Debt/EBITDA0.32
Balance Sheet
Debt/Equity0.37
Current Ratio3.09
Quick Ratio2.83
Book Value/Sh8.566 USD
Cash/Share5.749 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float18.94M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.91
S&P 52W Chg14.29%
Avg Vol (30d)—
Avg Vol (10d)—
Technical Indicators
RSI (14)0.0
MACD-0.0018
MACD Signal-0.0010
MACD Hist.-0.0008
BB Upper0.0120 USD
BB Middle0.0059 USD
BB Lower-0.0002 USD
BB Width206.69%
ATR (14)0.0006 USD
Vol Ratio (20d)113.73x